Workflow
Smartgiant(688115)
icon
Search documents
科创板资金动向:14股主力资金净流入超5000万元
Market Overview - The main funds in the Shanghai and Shenzhen markets experienced a net outflow of 14.265 billion yuan, while the Sci-Tech Innovation Board saw a net inflow of 722 million yuan [1] - A total of 257 stocks had net inflows, while 332 stocks had net outflows [1] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 379 stocks rose, with two stocks hitting the daily limit up, including Puyuan Information and Awei New Materials, while 200 stocks declined [1] - The top three stocks with the highest net inflow of funds were Cambrian Technology (76.922 million yuan), Haiguang Information (11.294 million yuan), and Hengxuan Technology (8.704 million yuan) [2] Continuous Fund Flow - There are 56 stocks that have seen continuous net inflows for more than three trading days, with Zhongkong Technology leading at seven consecutive days [2] - Conversely, 136 stocks have experienced continuous net outflows, with Guanda Materials leading at 18 consecutive days [2] Key Stocks with Fund Inflows - Cambrian Technology: 76.922 million yuan net inflow, 13.66% inflow rate, and a 4.90% increase [2] - Haiguang Information: 11.294 million yuan net inflow, 5.21% inflow rate, and a 0.63% increase [2] - Hengxuan Technology: 8.704 million yuan net inflow, 9.51% inflow rate, and a 0.63% increase [2] Key Stocks with Fund Outflows - Juchip Technology: 9.357 million yuan net outflow, with a 3.22% decrease [1] - SMIC: 8.240 million yuan net outflow [1] - Sitaiwei: 6.821 million yuan net outflow [1]
思林杰(688115) - 关于5%以上股东提前终止减持计划暨减持股份结果公告
2025-07-15 09:17
证券代码:688115 证券简称:思林杰 公告编号:2025-036 广州思林杰科技股份有限公司 关于 5%以上股东提前终止减持计划暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示: 股东持有的基本情况 截至本公告披露日,横琴启创天瑞投资企业(有限合伙)(以下简称"启创天 瑞")持有广州思林杰科技股份有限公司(以下简称"思林杰"或"公司")股份 4,799,500 股,占公司总股本的 7.20%,股份来源于公司首次公开发行前持有的股 份,已于 2023 年 3 月 14 日解除限售并上市流通。 减持计划的实施结果情况 2025 年 7 月 10 日,公司披露了《关于持股 5%以上股东减持股份计划公告》。 2025 年 7 月 15 日,公司收到启创天瑞的告知函,决定提前终止减持计划。启创 天瑞尚未开始实施减持,本次减持计划提前终止。 | 股东名称 | 启创天瑞 | | | | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | □是 ...
思林杰:5%以上股东提前终止减持计划
news flash· 2025-07-15 08:52
Core Viewpoint - The company announced that Hengqin Qichuang Tianrui Investment Enterprise (Limited Partnership) holds 4.7995 million shares, accounting for 7.20% of the company's total share capital. The investment firm has decided to terminate its share reduction plan ahead of schedule, which had not yet been implemented. The original plan was to reduce no more than 3% of its holdings [1] Summary by Relevant Sections - Shareholding Information - Hengqin Qichuang Tianrui Investment Enterprise holds 4.7995 million shares, representing 7.20% of the total share capital of the company [1] - Reduction Plan - The investment firm has decided to terminate its share reduction plan before it commenced, with the initial plan allowing for a reduction of up to 3% of its holdings [1]
思林杰(688115) - 关于公司2024年年度报告的信息披露监管问询函的回复公告
2025-07-14 11:00
证券代码:688115 证券简称:思林杰 公告编号:2025-035 广州思林杰科技股份有限公司 关于 2024 年年度报告的信息披露 监管问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 广州思林杰科技股份有限公司(以下简称"公司"或"思林杰")近日收到上海证 券交易所下发的《关于广州思林杰科技股份有限公司 2024 年年度报告的信息披露 问询函》(上证科创公函〔2025〕0267 号,以下简称"《问询函》"),公司董事 会对上述问询函提到的问题高度重视。根据问询函的要求,公司与民生证券股份有 限公司(以下简称"保荐机构"或"民生证券")及天健会计师事务所(特殊普通合伙) (以下简称"年审会计师"或"天健"),针对问询函相关问题进行了认真核查,现就 问询函所涉及问题回复如下: 在本问询函相关问题的回复中,本回复中涉及 2025 年数据均未经审计或审阅, 若合计数与各分项数值相加之和或相乘在尾数上存在差异,均为四舍五入所致。如 无特别说明,以下单位均为万元,本回复中使用的简称或名词释义与《广州思林杰 科技股 ...
思林杰(688115) - 天健会计师事务所(特殊普通合伙)关于思林杰2024年年度报告信息披露监管问询函的专项说明
2025-07-14 11:00
录 | 一、问询函专项说明………………………………………………………………… 第 1一17 页 | | --- | | (一) 关于主营业务 ……………………………………………… 第 1—10 页 | | (二) 关于应收应付 …………………………………………… 第 10—17 页 | | 二、资质证书复印件……………………………………………………第 18―21 页 | | --- | 问询函专项说明 天健函〔 2025 〕7-76 号 上海证券交易所: 由广州思林杰科技股份有限公司(以下简称思林杰公司或公司)转来的《关 于广州思林杰科技股份有限公司 2024年年度报告的信息披露监管问询函》(上 证科创公函〔2025〕0267 号,以下简称间询函)奉悉。我们已对间询函中需要 我们说明的财务事项进行了审慎核查,现汇报说明如下。 若无特殊说明,以下单位均为万元,数据取四舍五入。 基于商业敏感信息,根据相关法律法规及规范性文件,公司已履行相应信息 豁免披露程序,对本次问询函回复中涉及商业秘密事项进行豁免披露处理。 一、关于主营业务 年报显示,公司 2024 年实现营业收入 1. 85 亿元,同比增长 10. 14% ...
思林杰(688115) - 民生证券股份有限公司关于广州思林杰科技股份有限公司2024年年度报告的信息披露监管问询函回复的核查意见
2025-07-14 11:01
民生证券股份有限公司 关于广州思林杰科技股份有限公司 2024 年年度报告的信息披露监管问询函回复 的核查意见 上海证券交易所: 民生证券股份有限公司(以下称"民生证券""保荐机构")作为广州思林杰 科技股份有限公司(以下称"思林杰"或"公司")首次公开发行股票并在科创板 上市的保荐机构,于近日收到贵所下发的《关于广州思林杰科技股份有限公司 2024 年年度报告的信息披露问询函》(上证科创公函〔2025〕0267 号,以下简称 "《问询函》")后,会同公司及其他中介机构针对问询函问题进行了认真讨论充 分核查,现向贵所提交问询函回复的核查意见。 本核查意见中涉及 2025 年数据均未经审计或审阅,若合计数与各分项数值相 加之和或相乘在尾数上存在差异,均为四舍五入所致。本核查意见中使用的简称或 名词释义与《广州思林杰科技股份有限公司 2024 年年度报告》(以下简称"2024 年年报")一致。 请公司:(1)说明嵌入式智能仪器模块新研发产品的类型、内容、研发进展 和成果等情况,列示相应电子材料的采购成本及占比、截至目前变动情况;(2) 列示自动化生产测试设备前五名客户的名称、金额、毛利率、期后回款等情况,说 明其 ...
7月10日晚间重要公告一览
Xi Niu Cai Jing· 2025-07-10 10:23
Group 1 - Aishuo Co., Ltd. expects a net loss of 170 million to 280 million yuan for the first half of 2025, with a net loss of 410 million to 520 million yuan after excluding non-recurring gains and losses [1] - Changcheng Military Industry anticipates a net loss of 25 million to 29.5 million yuan for the first half of 2025, with a net loss of 35 million to 41 million yuan after excluding non-recurring gains and losses [1] - Changyuan Donggu expects a net profit of 155 million to 180 million yuan for the first half of 2025, representing a year-on-year increase of 62.65% to 88.88% [1] Group 2 - Beifang Navigation forecasts a net profit of 105 million to 120 million yuan for the first half of 2025, turning around from a loss of 74.2168 million yuan in the same period last year [3] - Xizi Clean Energy expects a net profit of 130 million to 180 million yuan for the first half of 2025, a decrease of 47.40% to 62.01% compared to the same period last year [4] - Tianbao Infrastructure anticipates a net profit of 90 million to 130 million yuan for the first half of 2025, representing a year-on-year increase of 1581.80% to 2329.27% [4] Group 3 - Taiping Bird expects a net profit of approximately 77.7 million yuan for the first half of 2025, a decrease of about 55% compared to the same period last year [6] - Xibu Chuangye forecasts a net profit of approximately 295 million yuan for the first half of 2025, an increase of 88.99% compared to the same period last year [8] - Zhengbang Technology expects a net profit of 190 million to 210 million yuan for the first half of 2025, a year-on-year increase of 249.03% to 264.72% [9] Group 4 - Songzhi Co., Ltd. anticipates a net profit of 140 million to 170 million yuan for the first half of 2025, representing a year-on-year increase of 53.58% to 86.49% [10] - Hailide expects a net profit of 280 million to 310 million yuan for the first half of 2025, a year-on-year increase of 47.65% to 63.47% [12] - Chenhua Co., Ltd. forecasts a net profit of 48.8176 million to 56.6284 million yuan for the first half of 2025, a year-on-year increase of 25% to 45% [13] Group 5 - Yuanlin Co., Ltd. expects a net loss of 68 million to 92 million yuan for the first half of 2025, with a net loss of 70 million to 95 million yuan after excluding non-recurring gains and losses [14] - Chuanhua Zhili anticipates a net profit of 500 million to 550 million yuan for the first half of 2025, representing a year-on-year increase of 72.78% to 90.06% [15] - Longyuan Technology expects a net profit of 26 million to 31 million yuan for the first half of 2025, a year-on-year increase of 116.61% to 158.26% [17] Group 6 - Jiangshan Co., Ltd. forecasts a net profit of 300 million to 360 million yuan for the first half of 2025, a year-on-year increase of 75.65% to 110.78% [32] - Ganli Pharmaceutical expects a net profit of 600 million to 640 million yuan for the first half of 2025, a year-on-year increase of 100.73% to 114.12% [33] - Zhongyan Chemical's subsidiary signed a 6.809 billion yuan mining rights transfer contract [35]
破发股思林杰股东拟减持 2022IPO超募4亿国联民生保荐
Zhong Guo Jing Ji Wang· 2025-07-10 06:36
Group 1 - The major shareholder, Qichuang Tianrui Investment, plans to reduce its stake in Silin Jie by up to 2,000,100 shares, representing a maximum of 3.00% of the total share capital [1] - Qichuang Tianrui currently holds 4,799,500 shares, which is 7.20% of the total share capital, and these shares became tradable on March 14, 2023 [1] - The reduction will occur through centralized bidding and block trading, with specific limits on the number of shares that can be sold within certain time frames [1] Group 2 - Silin Jie was listed on the Sci-Tech Innovation Board on March 14, 2022, with an initial public offering of 16.67 million shares at a price of 65.65 yuan per share [2] - The total funds raised by Silin Jie amounted to 1.094 billion yuan, with a net amount of 975 million yuan after deducting issuance costs, exceeding the original plan by 418 million yuan [2] - The company intended to use the raised funds for expansion projects and operational funding, but the stock is currently trading below its IPO price [2] Group 3 - The total issuance costs for Silin Jie were 119 million yuan, with the lead underwriter, Minsheng Securities, receiving 93.02 million yuan in underwriting fees [3] - The strategic placement involved Minsheng Investment, a subsidiary of the underwriter, which acquired 66,680 shares, amounting to 43.7754 million yuan, with a lock-up period of 24 months [3]
晚间公告丨7月9日这些公告有看头
第一财经· 2025-07-09 14:23
Core Viewpoint - The article summarizes important announcements from various listed companies in the Shanghai and Shenzhen stock markets, providing insights for investors regarding operational updates, stock performance, and significant corporate actions. Group 1: Company Announcements - Huaguang Huaneng's stock has experienced five consecutive trading limit increases, with a trading volume of 29.41% over the last five days, indicating potential irrational speculation, although the company's fundamentals remain stable [3]. - Andeli's actual controller Wang An transferred 90% of the shares of BVI Ping An to his daughter Wang Meng, but this transfer does not affect the company's governance structure or control [5]. - Singshan Co. received a court notice regarding the judicial disposal of 4.26 million shares, accounting for 0.19% of the total share capital, but this is not expected to impact daily operations [6]. - Three Gorges Energy reported a total power generation of 39.314 billion kWh in the first half of 2025, an increase of 8.85% year-on-year [7]. - New Zhonggang's stock has seen four consecutive trading limits, with no significant media reports or market rumors affecting its price [8]. - ST Yazhen's stock was suspended for one trading day due to a tender offer by its controlling shareholder, with a total of 55.1779 million shares involved [9]. - Zhongli Co. plans to invest 478 million yuan in a smart logistics equipment project [11]. - Zhuoran Co. approved the sale of 95% equity in a subsidiary for 723 million yuan, which does not constitute a related party transaction [12]. - Jerry Co. received a project award for a natural gas booster station worth approximately 850 million USD [13]. - Qujiang Cultural Tourism plans to publicly transfer 38% equity in a subsidiary valued at approximately 22.98 million yuan [14]. - Foshan Technology intends to publicly transfer 100% equity of a subsidiary with a starting price of 180 million yuan [15]. Group 2: Performance Forecasts - Xianda Co. expects a net profit increase of 2443.43% to 2834.73% in the first half of 2025, driven by rising product prices and improved cost control [25]. - Muyuan Co. anticipates a net profit of 10.5 billion to 11 billion yuan, reflecting a year-on-year growth of 924.6% to 973.39% due to increased pig sales and lower costs [26]. - Jiangshan Co. forecasts a net profit increase of 75.65% to 110.78% in the first half of 2025, supported by product optimization and cost control [28]. - Chenguang Bio's net profit is expected to rise by 102.33% to 132.38%, primarily due to improved market conditions for its cottonseed business [29]. - Xinlian Electronics predicts a net profit of 166 million to 198 million yuan, marking a turnaround from a loss in the previous year [30]. - Wohua Pharmaceutical expects a net profit increase of 233.89% to 378.27% due to market adaptation and cost control measures [31]. - Yonghe Co. anticipates a net profit increase of 126.30% to 148.49% driven by rising refrigerant prices [32]. - Shanghai Pharmaceuticals expects a net profit increase of approximately 52% due to the acquisition of a stake in a subsidiary [34]. - AVIC Heavy Machinery forecasts a net profit decline of about 33.29% due to falling product prices [35]. - Jingneng Real Estate expects a net loss of 190 million to 210 million yuan in the first half of 2025 due to reduced scale and increased expenses [36]. Group 3: Major Contracts - Fengfan Co. won a bid for a project worth approximately 337 million yuan from the Southern Power Grid [37]. - Longjian Co. was part of a consortium that won a project bid worth 362 million yuan for infrastructure construction [38].
7月10日上市公司重要公告集锦:先达股份上半年净利同比预增逾24倍
Zheng Quan Ri Bao· 2025-07-09 13:47
Group 1: Company Announcements - Huayin Power's stock has seen a significant short-term increase, with a cumulative rise of 79.82% since July 1, 2025, which is substantially higher than the industry and Shanghai Composite Index [5] - Zhongyan Chemical's subsidiary acquired natural soda mining rights for 6.80866 billion yuan [6] - Shudao Equipment has terminated the acquisition of a 65.43% stake in Keyi Gas [10] - New Link Electronics expects a net profit of 166 million to 198 million yuan for the first half of 2025, marking a turnaround from a loss of 41.2841 million yuan in the same period last year [12] Group 2: Profit Forecasts - Xian Da Co. anticipates a net profit increase of 2443.43% to 2834.73%, projecting 130 million to 150 million yuan for the first half of 2025 [2] - Shanghai Pharmaceuticals expects a net profit of 4.45 billion yuan for the first half of 2025, a 52% increase from the previous year [3] - Yonghe Co. forecasts a net profit of 255 million to 280 million yuan, representing a year-on-year increase of 126.30% to 148.49% [4] - Xiangyuan Cultural Tourism projects a net profit of 90 million to 97 million yuan, an increase of 51.44% to 63.22% [5] - Ganli Pharmaceutical expects a net profit of 600 million to 640 million yuan, a growth of 100.73% to 114.12% [6] - Jiangshan Co. anticipates a net profit of 300 million to 360 million yuan, reflecting a year-on-year increase of 75.65% to 110.78% [6] - Zhiwei Intelligent expects a net profit of 91.98 million to 112 million yuan, a growth of 62.85% to 99.06% [9] - Wanliyang forecasts a net profit of 270 million to 290 million yuan, an increase of 46.68% to 57.55% [11] - Wohua Pharmaceutical expects a net profit of 37 million to 53 million yuan, a significant increase of 233.89% to 378.27% [14] - Chenguang Biological anticipates a net profit of 202 million to 232 million yuan, a growth of 102.33% to 132.38% [15] - Muyuan Foods expects a net profit of 10.5 billion to 11 billion yuan, a staggering increase of 924.6% to 973.39% [15] - New Beiyang forecasts a net profit of 34.7 million to 38.2 million yuan, a growth of 100% to 120% [16]